Phase 2 Conjunctivitis Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis
Moderate to Severe Vernal Keratoconjunctivitis
Laboratoires Thea120 enrolled11 locationsNCT07169695
Recruiting
Phase 2
Evaluation of TL-925 for the Treatment of Seasonal Allergic Conjunctivitis
allergic conjunctivitis
Telios Pharma, Inc.60 enrolled1 locationNCT07220408
Recruiting
Phase 2
Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis
allergic conjunctivitis
Telios Pharma, Inc.66 enrolled1 locationNCT06686472
Recruiting
Phase 2
OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis
Infectious ConjunctivitisViral Conjunctivitis
Okogen Pty Ltd219 enrolled7 locationsACTRN12619000177156
Not Yet Recruiting
Phase 2
A Pilot Study: The effect of in-office irrigation with 5% povidone-iodine to reduce the duration of adenoviral conjunctivitis
Adenoviral conjunctivitis
Ben Ashby12 enrolled1 locationACTRN12613000460707